Respiratory Panel

​

A Respiratory Panel is a comprehensive diagnostic test that identifies the specific viruses, bacteria, and sometimes fungi responsible for respiratory infections. Utilizing advanced molecular techniques, such as polymerase chain reaction (PCR), this panel can detect a wide array of pathogens from a single sample, typically a nasal or throat swab. The Respiratory Panel is especially valuable in settings where quick and accurate identification of the infectious agent is crucial for timely and appropriate treatment.

Key features and benefits of a Respiratory Panel include:

1. Broad Range Detection: Capable of identifying multiple respiratory pathogens, including influenza viruses (A and B), respiratory syncytial virus (RSV), various strains of coronavirus (including SARS-CoV-2), adenovirus, rhinovirus, enterovirus, and bacterial pathogens such as Mycoplasma pneumoniae and Bordetella pertussis, among others.

2. Speed and Accuracy: Delivers results faster than traditional culture methods, often within hours, allowing for rapid diagnosis and the initiation of targeted treatment.

3. Improved Patient Outcomes: By identifying the specific cause of infection, healthcare providers can choose the most effective therapies, avoid unnecessary antibiotic use, and take appropriate infection control measures.

4. Epidemiological Surveillance: Helps in tracking the prevalence and spread of respiratory pathogens within communities, informing public health interventions and responses.

The Respiratory Panel is particularly useful during flu seasons, outbreaks of respiratory diseases, and for patients with severe or atypical respiratory symptoms. It assists in distinguishing between viral and bacterial infections, guiding treatment decisions, and in some cases, preventing the spread of infections, especially in hospital or long-term care settings